Retinoblastoma is a rare type of eye cancer and occurs most often in children under the age of 5. It accounts for approximately 2% of all cancers that occur in children between the age of 0 -14 years of age. Some commonly used procedures to diagnose retinoblastoma include: eye exams, eye ultrasounds, and magnetic resonance imaging.

The underlying cause of retinoblastoma are mutations in the retinoblastoma gene, resulting in the production of a mutated retinoblastoma protein. The protein’s ability to control cell division is negatively impacted, ultimately leading to the formation of tumours as seen in retinoblastoma.

Current treatment options for retinoblastoma include: cryosurgery, thermotherapy, laser surgery, radiation therapy, chemotherapy and enucleation. In addition to current treatments, researchers continue to investigate new and innovative methods for treating retinoblastoma.

Subscribe to the McMaster Demystifying Medicine YouTube channel:

This video is provided for general and educational information only. Please consult your health care provider for Information about your health.

[Please complete our feedback form]



Author Details


  • Abby W. Staging and classifying intraocular retinoblastoma [Internet]. WE C Hope. 2019 [cited 2022 Feb 13]. Available from:
  • Biswas J, Kandalam M, Mitra M, Subramanian K. Molecular pathology of retinoblastoma. Middle East African Journal of Ophthalmology. 2010;17(3):217.
  • Capizano T. Strabismus [Internet]. Strabismus - American Association for Pediatric Ophthalmology and Strabismus. 2021 [cited 2022 Feb 8]. Available from:
  • Cell Cycle: Definition, Phases, and Diagram [Internet]. Science Facts. 2020. Available from:
  • Information (US) NC for B. Chromosome Map. National Center for Biotechnology Information (US); 1998
  • Correa Z, Berry J. Review of retinoblastoma. Pediatric ophthalmology education center. Flower Mound: American Academy of Ophthalmology.:2016.
  • Debrowski A. Heterochromia FAQs [Internet]. All About Vision. All About Vision; 2022 [cited 2022 Feb 8]. Available from:
  • Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, Gallie BL. Retinoblastoma. Nature reviews Disease primers. 2015 Aug 27;1(1):1-23.
  • Eagle Jr. RC. Retinoblastoma and simulating lesions [Internet]. Ento Key. 2016 [cited 2022 Feb 8]. Available from:
  • Eidsmoe K. Retinoblastoma stages [Internet]. American Cancer Society. 2018 [cited 2022 Feb 13]. Available from: staging/staging.html
  • Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. British Journal of Ophthalmology. 2009 Sep 1;93(9):1129-31
  • Lee S. Retinoblastoma [Internet]. Canadian Cancer Society. 2022 [cited 2022 Feb 4]. Available from:
  • Lohmann DR, Gallie BL. Retinoblastoma. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Gripp KW, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993.
  • Mayo Clinic Staff. Retinoblastoma [Internet]. Mayo Clinic. Mayo Foundation for Medical Education and Research; 2021 [cited 2022 Feb 4]. Available from:
  • Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012 Apr;33(2):80-8.
  • Miles K. Periorbital cellulitis [Internet]. BabyCenter. [cited 2022 Feb 8]. Available from:
  • Pandey AN. Retinoblastoma: An overview. Saudi J Ophthalmol. 2014 Oct;28(4):310–5.
  • Park BH, Vogelstein B. Retinoblastoma—a paradigm for tumor-suppressor gene function. Holland-Frei Cancer Medicine 6th edition. 2003
  • Retinoblastoma (hereditary predisposition) [Internet]. Available from:
  • White A. Staging and classifying intraocular retinoblastoma [Internet]. WE C Hope. 2019 [cited 2022 Feb 13]. Available from:
Accessibility for Ontarians With Disabilities Act (AODA)


The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at